Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Comment by PTBaileyon Sep 27, 2021 4:26pm
155 Views
Post# 33925529

RE:Delays Delays !!!

RE:Delays Delays !!!

HighSkies2019 wrote: Hey Bud ....yes certainly seems to be hold up after hold up ....and our time frame pushed out further .. I did read up on PP and it normally takes 6 to 8 wks ...I just hope the delay at TSX as posted by Bailey is something that can be easily rectified...there are a few questions that need answeres and could be held back for the reason that the answeres could be what pushes our price up...with them coming out with a nr on a new lisence avenue to cover ARDS and needing clearance again with TSX .. I can't see TSX allowing if not enough funds are in place .. I see Health Canada gave a pass to SazNOtize in Aug to run a 3rd trial in CDA but needs to also be done via prescription release not over the counter ...so this gives confidence that health cda will maybe give support to our R107 trials or possible emergency use if nitric oxide truly has the potential to fight off covid and save lives ....Friday is Oct 1 ....I understand delays can happen and its hurdle after hurdle in this case ...but something needs to come out shortly and hopefully with concrete news that gives investors confidence the price will run up and stay....or many investors will jump ship just to brake even or get some return ... I can't see Clas mgmt pushing this far and getting finance coverage if they don't believe in what they are doing ....I do expect some update direct from the company since they had meeting last Thursday with TSX ....maybe we will get surprised ...but the longer the delays makes other questionable scenarios come to mind ...heres hoping for great news..glta

 


Definetly need to get this puppy off the launching pad.

<< Previous
Bullboard Posts
Next >>